LobbyingCastle Biosciences lobbying by quarter
Castle Biosciences CSTL's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q3 2023; the issues it reports most are Medicare/Medicaid.
Castle BiosciencesCSTL
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $120K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $30K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $60K | 1 |
| Q2 2024 | $40K | 1 |
| Q3 2024 | $40K | 1 |
| Q4 2024 | $40K | 1 |
| Q1 2025 | $40K | 1 |
| Q2 2025 | $40K | 1 |
| Q3 2025 | $40K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $40K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$510K · 12 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES12 reports
- SENATE12 reports
- Centers For Medicare and Medicaid Services (CMS)11 reports
- Executive Office of the President (EOP)11 reports
- Health & Human Services, Dept of (HHS)11 reports
Firms it paid
| Firm | ||
|---|---|---|
| McDermott+ | $510K | 12 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| AMY KELBICK | 2015-2017: Senior Policy Advisor, Rep. Jan Schakowsky; 2013-2015: Senior Legislative Assistant, Rep. Bill Foster; 2009-2013: Legislative Assistant, Staff Assistant, Rep. Maurice Hinchey | Q2 2026 |
| JOSH JORGENSEN | 2017-2020: Senior Legislative Correspondent; Legislative Aide, Sen. Mike Rounds | Q2 2026 |
| LEIGH FELDMAN | 2016-2017: Senate Finance Committee (Detailee) | Q2 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/06for Q2 | McDermott+ | $40K |
| 04/02for Q1 | McDermott+ | $40K |
| 01/05for Q4 2025 | McDermott+ | $40K |
| 25/10/03for Q3 2025 | McDermott+ | $40K |
| 25/06/30for Q2 2025 | McDermott+ | $40K |
| 25/04/08for Q1 2025 | McDermott+ | $40K |
| 25/01/06for Q4 2024 | McDermott+ | $40K |
| 24/10/03for Q3 2024 | McDermott+ | $40K |
| 24/07/09for Q2 2024 | McDermott+ | $40K |
| 24/04/01for Q1 2024 | McDermott+ | $60K |
| 24/01/05for Q4 2023 | McDermott+ | $60K |
| 23/10/06for Q3 2023 | McDermott+ | $30K |
| 23/09/29for Q3 2023 | McDermott+ | Under $5,000 |